F-Term-List

C07K1/00-19/00

AA00
TYPE OF INVENTION

AA10

. Substances

AA11

AA20

. . Antigens or antibodies

. Processes of preparation

AA30

. Use

AA40

. Apparatus

AA50

. Others

BA00
CHEMICAL CONSTITUTION

BA01

BA05

BA09

BA10

. containing D-alpha-amino acids

. characterised by three-dimensional structure

. having known amino acid compositions

. The number of alpha-amino acids

BA11

BA12

BA13

BA14

BA15

BA16

BA17

BA18

BA19

BA20

. . 2

. . 3

. . 4-5

. . 6-7

. . 8-10

. . 11-14

. . 15-23

. . 24-35

. . 36-50

. . 51-70

BA21

BA30

. . 71-100

. Cyclic peptides

BA31

BA32

BA33

BA34

BA35

BA40

. . having rings including bonds other than peptide bonds

. . . Sulfur-sulfur (S-S) bonds

. . . Ester bonds

. . . Amide bonds

. . having rings of only peptide bonds

. Conjugates of heterologous proteins or peptides

BA41

BA42

BA50

. . Fusion proteins

. . bonded with carriers comprising proteins

. having characteristic constituents

BA51

BA52

BA53

BA54

BA55

BA56

BA57

BA60

. . Heterocyclic compounds

. . Organometallic compounds

. . Sugars or polysaccharides

. . Nucleotides or nucleic acids

. . Steroids or lipids

. . Macromolecular compounds

. . . Polyalkylene glycols

. . Immobilised carriers

BA61

BA62

BA63

BA70

. . . Natural macromolecules

. . . Synthetic macromolecules

. . . Inorganic compounds

. . Pigments

BA71

BA72

. . Radioactive components

. . Toxins or chemical agents

CA00
ORIGIN

CA01

CA02

CA03

CA04

CA05

CA10

. Viruses

. . Hepatitis viruses

. . Herpes viruses

. . Leukemia viruses

. . Human immunodeficiency viruses

. Fungi or lichens

CA11

CA15

CA20

. . Bacteria or actinomycetales

. . True fungi

. Protozoa

CA21

CA22

CA30

. . Coccidia

. . Plasmodia

. Plants

CA31

CA32

CA33

CA40

. . Cereals

. . . Wheat varieties

. . Beans

. Mammals or birds

CA41

CA42

CA43

CA44

CA45

CA46

CA50

. . Tumour cells

. . Bloods

. . Milks

. . Urines or urinary organs

. . Nerves or brains

. . Placentas or amniotic fluids

. Other animals

CA51

CA52

CA53

. . Insects

. . Fishes

. . Reptiles or amphibians

DA00
PEPTIDE OR PROTEIN CHARACTERISED BY FUNCTION

DA01

DA02

DA03

DA04

DA05

DA10

. Cytokines

. . Interleukins

. . . Interleukin-1

. . . Interleukin-2

. . . Interleukin-3

. . Colony-stimulating factors

DA11

DA12

DA13

DA14

DA15

DA16

DA17

DA18

DA20

. . . Granulocyte-colony stimulating factors (G-CSFs)

. . . Granulocyte-macrophage colony stimulating factors (GM-CSFs)

. . Erythropoietins

. . Tumour necrosis factors or lymphotoxins

. . Interferons

. . . Alpha-interferons

. . . Beta-interferons

. . . Gamma-interferons

. . Epidermal growth factors

DA21

DA22

DA30

. . Nerve growth factors

. . Tumour growth factors

. Hormones

DA31

DA32

DA33

DA34

DA35

DA36

DA37

DA38

. . Growth hormones

. . Natriuretic peptides

. . Opioid peptides

. . Oxytocins or vasopressins

. . Somatostatins

. . Calcitonins

. . Insulins

. . Insulin-like growth factors or somatomedins

DA45

DA46

DA47

DA50

. Hormone-releasing or hormone-inhibiting factors

. . Growth hormone-releasing factors

. . Luteinising hormone-releasing hormones

. Receptors or cell surface proteins

DA51

DA55

DA56

DA57

DA58

. . Receptors of cytokines

. Enzyme inhibitors

. . Protease inhibitors

. . . Angiotensin converting enzyme inhibitors

. . . Renin inhibitors

DA65

DA66

DA70

. Blood coagulation factors

. . Factors VIII

. Albumins

DA75

DA76

DA80

. Immunoglobulins or antibodies

. . Monoclonal antibodies

. Lectins

DA83

DA86

DA89

. Toxins e.g. protein synthesis inhibitors

. Antigens

. Enzymes

EA00
USE

EA01

EA02

EA05

EA06

EA07

. Foods or brewing

. . Sweeteners

. Agriculture forestry and fishery industries

. . Insecticides or fungicides

. . Animal-feeding stuffs

EA15

EA20

. Cosmetics or shampoos

. Pharmaceuticals

EA21

EA22

EA23

EA24

EA25

EA26

EA27

EA28

EA29

EA30

. . acting on central nervous systems

. . acting on biological defence mechanisms

. . acting on circulatory organs

. . acting on hematopoietic organs bloods or body liquids

. . acting on digestive organs

. . acting on urogenital organs

. . acting on metabolic systems

. . acting on functions of tissue cells

. . acting on pathogenetic organisms

. . Hormone-like agents

EA31

EA34

EA35

EA36

EA40

. . Vaccines

. Materials for medical purposes

. Surfactants

. Detergents

. Photographic or printing materials

EA45

EA50

. Electric or communication materials

. Analytical or diagnostic materials

EA51

EA52

EA53

EA54

EA55

EA60

. . Cancers or tumours

. . Infectious diseases

. . . Virus infections

. . Cell surface antigens

. . Substrates for enzyme activity measurements

. Others

EA61

EA62

EA65

. . using chemical properties

. . Synthetic intermediates

. . using physical properties

FA00
PROCESS OF PREPARATION

FA10

. by chemical syntheses

FA15

FA16

FA20

. . by cutting peptide bonds

. . . Hydrolysis

. . by formation of peptide bonds

FA30

. . . Liquid phase processes

FA31

FA32

FA33

FA34

FA40

. . . . Stepwise elongation processes

. . . . Fragment condensation processes

. . . Solid phase processes

. . . . Automatic syntheses

. . . Processes for forming peptide bonds

FA41

FA42

FA43

FA44

FA50

. . . . Active ester processes

. . . . Mixed acid anhydride processes

. . . . Azide processes

. . . . Dicyclohexylcarbodiimide (DCC) processes

. . by chemical modifications other than cutting or forming peptide bonds

FA51

FA52

FA53

FA57

FA58

FA59

FA60

. . . of nitrogen-terminal amino groups or carbon-terminal carboxyl groups

. . . of amino acid side chains

. . . of non-amino acid components

. . Protection of functional groups

. . . Amino groups

. . . Carboxyl groups

. . . Other side chain functional groups

FA61

FA65

FA67

FA70

. . Removal of protecting groups

. Denaturation

. Regeneration or reactivation

. Enzyme processes

FA71

FA72

FA73

FA74

FA80

. by organisms

. . Cell culture or tissue culture

. . Fermentation processes

. . Gene recombinations

. Immobilisation processes

FA81

FA82

FA83

FA84

. . by covalent bonds

. . by adsorption

. . by crosslinking

. . by encapsulation into lattices

GA00
SEPARATION, PURIFICATION, OR STABILISATION

GA01

GA05

GA06

GA10

. Extraction or solubilisation

. Precipitation

. . Salting out

. Ultrafiltration

GA15

GA20

. Centrifugation

. by adsorption

GA21

GA22

GA23

GA24

GA25

GA26

GA30

. . Chromatography

. . . Gel chromatography

. . . Ion-exchange chromatography

. . . Hydroxyapatite chromatography

. . . Reverse phase chromatography

. . . Affinity chromatography

. Electrophoresis

GA31

GA32

GA33

GA40

. . Polyacrylamide gel electrophoresis

. . Isoelectric focusing

. . Two-dimensional electrophoresis

. Crystallisation

GA45

. Stabilisation

HA00
PHYSICOCHEMICAL PROPERTY

HA01

HA02

HA03

HA04

HA05

HA06

HA07

HA10

. Molecular weights (MW)

. . MW <= 1000

. . 1000 < MW <= 5000

. . 5000 < MW <= 10000

. . 10000 < MW <= 50000

. . 50000 < MW <= 100000

. . 100000 < MW

. Isoelectric points (PI)

HA11

HA12

HA13

HA14

HA15

HA16

HA17

HA18

HA19

HA20

. . PI <= 2.0

. . 2.0 < PI <= 3.0

. . 3.0 < PI <= 4.0

. . 4.0 < PI <= 5.0

. . 5.0 < PI <= 6.0

. . 6.0 < PI <= 7.0

. . 7.0 < PI <= 8.0

. . 8.0 < PI <= 9.0

. . 9.0 < PI <= 10.0

. . 10.0 < PI <= 11.0

HA21

HA30

. . 11.0 < PI

. Solubility

HA31

HA32

. . soluble in water

. . soluble in organic solvents

4H045	PEPTIDES OR PROTEINS
	C07K1/00 -19/00